Ignite Creation Date:
2025-12-25 @ 3:43 AM
Ignite Modification Date:
2026-03-03 @ 12:19 AM
Study NCT ID:
NCT05368402
Status:
TERMINATED
Last Update Posted:
2025-02-03
First Post:
2022-05-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.
Sponsor:
Dompé Farmaceutici S.p.A
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LDX0122
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None